INS and type 1 diabetes mellitus: In a multisite, retrospective study of 873 pediatric, adolescent, and adult patients with type 1 diabetes in the United States, Layne et al.3 reported clinically meaningful improvement in glycemic outcomes for patients initiating therapy with the tubeless insulin management system compared to previous treatment with multiple daily injections (MDI) and tubed pumps.